675. The Fidaxomicin Cascade: Analysis of Success Rates and Barriers of Fidaxomicin Discharge Prescriptions for Inpatients Diagnosed with Clostridiodes Difficile

BACKGROUND: Current IDSA guidelines prefer Fidaxomicin for initial and first recurrent Clostridiodes difficile (C. difficile) infection. A barrier to increasing Fidaxomicin usage has been the medication’s potential high co-pay. The objective of this study was to evaluate the discharge success rate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Ellen, Mehta, Jigar, Blecher, Alexis L, Lee, Matthew S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679246/
http://dx.doi.org/10.1093/ofid/ofad500.737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679246/
http://dx.doi.org/10.1093/ofid/ofad500.737

Ejemplares similares